Article
Sox2 promotes tamoxifen resistance in breast cancer cells
31 Oct 2013
Abstract excerpt
Development of resistance to therapy continues to be a serious clinical problem in breast cancer management. Cancer stem/progenitor cells have been shown to play roles in resistance to chemo‐ and radiotherapy. Here, we examined their role in the development of resistance to the oestrogen receptor antagonist tamoxifen. Tamoxifen‐resistant cells were enriched for stem/progenitors and expressed high levels of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
